Literature DB >> 11115720

Impact of hepatitis B immunisation as part of the EPI.

Y Poovorawan1, A Theamboonlers, T Vimolket, S Sinlaparatsamee, K Chaiear, T Siraprapasiri, S Khwanjaipanich, S Owatanapanich, P Hirsch, S Chunsuttiwat.   

Abstract

Since 1992, hepatitis B vaccine has been an integrated part of Thailand's expanded programme on immunisation (EPI). Based on the data from five representative provinces, we have evaluated its impact on the countrywide prevalence of HBV infection and carrier rate. The population studied comprised 400-488 healthy and immuno-competent, subjects per area. The subjects' ages ranged from 6 months to 18 years. We examined their sera for viral hepatitis markers using commercially available test kits and established the coverage rate of hepatitis B vaccination after its inclusion into the EPI to be 71.2-94.3%. The number of individuals undergoing the complete course of vaccinations had increased four-fold. Consequently, only 0.7% of the children born after the implementation of this the novel EPI strategy were HBV carriers.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11115720     DOI: 10.1016/s0264-410x(00)00216-4

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  12 in total

1.  Epidemiology of hepatitis B virus infection in Albania.

Authors:  Bashkim Resuli; Skerdi Prifti; Bledar Kraja; Tatjana Nurka; Mimoza Basho; Edita Sadiku
Journal:  World J Gastroenterol       Date:  2009-02-21       Impact factor: 5.742

2.  Prevalence, risk factors, and impact of isolated antibody to hepatitis B core antigen and occult hepatitis B virus infection in HIV-1-infected pregnant women.

Authors:  Woottichai Khamduang; Nicole Ngo-Giang-Huong; Catherine Gaudy-Graffin; Gonzague Jourdain; Weerapong Suwankornsakul; Tapnarong Jarupanich; Veeradate Chalermpolprapa; Sirisak Nanta; Noossara Puarattana-Aroonkorn; Sakchai Tonmat; Marc Lallemant; Alain Goudeau; Wasna Sirirungsi
Journal:  Clin Infect Dis       Date:  2013-03-13       Impact factor: 9.079

Review 3.  [Viral infections of the fetus and newborn infant].

Authors:  S Tremolada; S Delbue; P Ferrante
Journal:  Pediatr Med Chir       Date:  2008 Jul-Aug

4.  Short term evaluation of a rural immunization program in Nigeria.

Authors:  O O Odusanya; J E Alufohai; F P Meurice; R Clemens; V I Ahonkhai
Journal:  J Natl Med Assoc       Date:  2003-02       Impact factor: 1.798

5.  Analysis of residual perinatal transmission of hepatitis B virus (HBV) and of genetic variants in human immunodeficiency virus and HBV co-infected women and their offspring.

Authors:  Woottichai Khamduang; Catherine Gaudy-Graffin; Nicole Ngo-Giang-Huong; Gonzague Jourdain; Alain Moreau; Thitiporn Borkird; Prapaisri Layangool; Nareerat Kamonpakorn; Weerachai Jitphiankha; Ratchanee Kwanchaipanich; Sathit Potchalongsin; Marc Lallemant; Wasna Sirirungsi; Alain Goudeau
Journal:  J Clin Virol       Date:  2013-08-02       Impact factor: 3.168

6.  Hepatocellular carcinoma: focus on different aspects of management.

Authors:  Sene Waly Raphael; Zhang Yangde; Chen Yuxiang
Journal:  ISRN Oncol       Date:  2012-05-13

7.  Aflatoxin-induced TP53 R249S mutation in hepatocellular carcinoma in Thailand: association with tumors developing in the absence of liver cirrhosis.

Authors:  Stephanie Villar; Sandra Ortiz-Cuaran; Behnoush Abedi-Ardekani; Doriane Gouas; Andre Nogueira da Costa; Amelie Plymoth; Thiravud Khuhaprema; Anant Kalalak; Suleeporn Sangrajrang; Marlin D Friesen; John D Groopman; Pierre Hainaut
Journal:  PLoS One       Date:  2012-06-04       Impact factor: 3.240

8.  Serological evidence of hepatitis A, B, and C virus infection in older adults in Khon Kaen, Thailand and the estimated rates of chronic hepatitis B and C virus infection in Thais, 2017.

Authors:  Nawarat Posuwan; Viboonsak Vuthitanachot; Teeraporn Chinchai; Rujipat Wasitthankasem; Nasamon Wanlapakorn; Yong Poovorawan
Journal:  PeerJ       Date:  2019-08-19       Impact factor: 2.984

9.  The Success of a Universal Hepatitis B Immunization Program as Part of Thailand's EPI after 22 Years' Implementation.

Authors:  Nawarat Posuwan; Nasamon Wanlapakorn; Pattaratida Sa-Nguanmoo; Rujipat Wasitthankasem; Preeyaporn Vichaiwattana; Sirapa Klinfueng; Viboonsak Vuthitanachot; Siriporn Sae-Lao; Monthana Foonoi; Apinya Fakthongyoo; Jamorn Makaroon; Klaita Srisingh; Duangporn Asawarachun; Somchai Owatanapanich; Norra Wutthiratkowit; Kraisorn Tohtubtiang; Pornsak Yoocharoen; Sompong Vongpunsawad; Yong Poovorawan
Journal:  PLoS One       Date:  2016-03-03       Impact factor: 3.240

10.  Impact of the universal hepatitis B immunization program in Mongolia: achievements and challenges.

Authors:  Dambadarjaa Davaalkham; Toshiyuki Ojima; Ritei Uehara; Makoto Watanabe; Izumi Oki; Steven Wiersma; Pagvajav Nymadawa; Yosikazu Nakamura
Journal:  J Epidemiol       Date:  2007-05       Impact factor: 3.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.